Page 71 - Glucose Monitoring Devices
P. 71

An extended illustration   69




                  Observations from the illustrative example
                  Based on our approach, we showed that there is a clear relationship between BGM
                  system accuracy and clinical outcomes, with the highest costs being associated with
                  meter systems not meeting the ISO 15197:2003 standard. Our analysis makes it clear
                  that BGM systems compliant with the ISO 15197:2013 standard have a limited
                  effect on HbA1c, severe hypoglycemia incidence, total daily insulin, and fingerstick
                  frequency. For the top 50% BGM systems complying with ISO 15197:2013, the
                  worst observed effect on the HbA1c values was 0.12% (absolute) while the worst
                  increase in SHE cases could reach 0.36 cases PPY. Compare this to the results for
                  the group of BGM systems, not compliant with any ISO standard: for the HbA1c
                  values, the increases could reach approximately 0.47% while the number of annual
                  SHE could increase by up to 1.70 cases per year (it is important to understand that
                  the system leading to an increase in HbA1c of 0.47% is not the same as the one
                  increasing the SHE by 1.70 cases PPY!). In addition, insulin consumption could
                  increase by up to 5.5 units/day and the number of fingersticks by up to 1.0 tests/day.
                     Lower costs are associated with systems meeting the ISO 15197:2013 standard.
                  Using BGM systems that meet the system accuracy criteria of the ISO 15197:2013
                  standard can help reduce the clinical and financial consequences associated with the
                  inaccuracy of BGM devices. The worst-case analysis shows that compliance with
                  stricter accuracy standards reduces clinical and financial risk for patients and
                  healthcare systems.
                     Bias is the accuracy characteristic that has the biggest influence on HbA1c, and
                  both BGM system error and bias have a significant effect on the incidence of severe
                  hypoglycemia.

                      Average Additional Cost           Worst-Case Additional Cost
                            Lower    Upper                       Lower   Upper
                             50%     50%                         50%      50%



                             £79     £64     Compliant  ISO 15197:2013  £278  £145  Compliant  ISO 15197:2013

                    £306                                £597



                                £216         Compliant  Not          £440        Compliant  Not


                     Not     ISO 15197:2003              Not      ISO 15197:2003
                  Compliant    Compliant               Compliant    Compliant
                  FIGURE 4.12
                  Costs associated with compliance with ISO standards of accuracy [34].
   66   67   68   69   70   71   72   73   74   75   76